01.012.LABS_Surat Pengantar LK 2025.pdf

UBC Medical
Indonesia

Jakarta, 27 Maret 2026
No.: 01.012/CS-MM/LABS/!!1/26

Kepada Yth.:

Direktur Penilaian Keuangan Perusahaan
Sektor Riil Otoritas Jasa Keuangan

Gedung Soemitro Djojohadikusumo Lantai 4
Jalan Lapangan Banteng Timur No. 2-4 Jakarta
10710

Perihal:

Penyampaian Laporan Keuangan Konsolidasian
Per 31 Desember 2025 (audited) PT UBC
Medical Indonesia Tbk

Dengan hormat,

Berdasarkan Peraturan Otoritas Jasa Keuangan
Nomor 7/POJK.04/2018 Tentang Penyampaian
Laporan Melalui Sistem Pelaporan Elektronik
Emiten Atau Perusahaan Publik, maka bersama
surat ini kami sampaikan 1 salinan elektronik
(soft copy) Laporan Keuangan Konsolidasian per
tanggal 30 Desember 2025 (audited) dan Check
List Laporan Keuangan.

Demikian kami sampaikan. Atas perhatiannya
kami ucapkan terima kasih.

Jakarta, 27” March 2026
No.: 01.012/CS-MM/LABS/!11/26

To:

Director of Financial Assessment of Real Sector
Companies, Financial Services Authority
Sumitro Djojohadikusumo Building

Ministry of Finance of the Republic of Indonesia
Jl. Lapangan Banteng Timur No. 1-4

Jakarta 10710

Subject:

Submission of Consolidated Financial
Statements as of December 30, 202 (audited) of
PT UBC Medical Indonesia Tbk

With due respect,

Based on Financial Services Authority Regulation
Number 7/POJK.04/2018 Concerning Submission
Of Reports Through the Electronic Reporting
System of Issuers or Public Companies, we
hereby submit 1 electronic copy (soft copy) of the
Consolidated Financial Report as of December
30, 2025 (audited) and the Financial Report
Checklist.

Thus we convey. Thank you for your attention.

PT UBC MEDICAL INDONESIA Tbk

Head Office :

Kawasan Industri Pulogadung

JI Rawa Gelam V, Blok. L, Kav.11-13
Jakarta — 13930

(021) 38865110
Info.ubc@ubcindonesia.com

www.ubcindonesia.com

jun,
Direktur Utama/President Director